Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells $30,003.84 in Stock

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the firm's stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $5.76, for a total value of $30,003.84. Following the completion of the sale, the chief operating officer now owns 86,044 shares of the company's stock, valued at approximately $495,613.44. This represents a 5.71 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Daniel Lesueur also recently made the following trade(s):

• On Monday, January 6th, Daniel Lesueur sold 5,209 shares of Health Catalyst stock. The stock was sold at an average price of $7.51, for a total value of $39,119.59.

Health Catalyst Stock Up 1.7 %

Shares of Health Catalyst stock traded up $0.10 during trading on Monday, hitting $5.80. 279,130 shares of the stock traded hands, compared to its average volume of 788,549. The firm has a market cap of $352.63 million, a P/E ratio of -4.30 and a beta of 1.34. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32. Health Catalyst, Inc. has a 52-week low of $5.32 and a 52-week high of $10.31. The stock's fifty day simple moving average is $6.80 and its 200 day simple moving average is $7.41.

Hedge Funds Weigh In On Health Catalyst

Institutional investors have recently made changes to their positions in the company. AQR Capital Management LLC purchased a new position in Health Catalyst in the second quarter valued at about $564,000. The Manufacturers Life Insurance Company boosted its holdings in Health Catalyst by 10.3% in the second quarter. The Manufacturers Life Insurance Company now owns 23,162 shares of the company's stock worth $148,000 after acquiring an additional 2,164 shares in the last quarter. Mackenzie Financial Corp acquired a new stake in Health Catalyst in the second quarter worth about $70,000. Essex Investment Management Co. LLC acquired a new stake in Health Catalyst in the third quarter worth about $2,012,000. Finally, Creative Planning lifted its holdings in shares of Health Catalyst by 13.2% during the third quarter. Creative Planning now owns 21,348 shares of the company's stock worth $174,000 after purchasing an additional 2,486 shares during the period. Hedge funds and other institutional investors own 85.00% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HCAT. Royal Bank of Canada lowered their price target on Health Catalyst from $9.00 to $7.00 and set a "sector perform" rating for the company in a research report on Wednesday, January 15th. Citigroup lowered their price target on Health Catalyst from $10.50 to $10.00 and set a "buy" rating for the company in a research report on Friday, January 10th. Canaccord Genuity Group decreased their target price on Health Catalyst from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Tuesday, January 21st. Stephens lifted their target price on Health Catalyst from $7.00 to $9.00 and gave the stock an "equal weight" rating in a research report on Thursday, November 14th. Finally, KeyCorp upgraded Health Catalyst from a "sector weight" rating to an "overweight" rating and set a $9.00 target price for the company in a research report on Wednesday, January 8th. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $10.60.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.